Outcome . | Deaths (n) . | Diabetes . | CHF . | ||
---|---|---|---|---|---|
RR . | 95% CI . | RR . | 95% CI . | ||
Infection-related mortality | 301 | 2.0* | (1.2–3.2) | 2.8* | (1.6–5.1) |
Infection as underlying cause | 111 | 1.9 | (0.9–4.0) | 0.9 | (0.3–3.5) |
Infection-related death with CVD† | 145 | 3.0* | (1.8–5.0) | 5.2* | (2.6–10.6) |
Infection-related death without CVD† | 156 | 1.0 | (0.5–2.2) | 0.5 | (0.2–1.7) |
Outcome . | Deaths (n) . | Diabetes . | CHF . | ||
---|---|---|---|---|---|
RR . | 95% CI . | RR . | 95% CI . | ||
Infection-related mortality | 301 | 2.0* | (1.2–3.2) | 2.8* | (1.6–5.1) |
Infection as underlying cause | 111 | 1.9 | (0.9–4.0) | 0.9 | (0.3–3.5) |
Infection-related death with CVD† | 145 | 3.0* | (1.8–5.0) | 5.2* | (2.6–10.6) |
Infection-related death without CVD† | 156 | 1.0 | (0.5–2.2) | 0.5 | (0.2–1.7) |
Data are adjusted for age, sex, race, diabetes, CHF, adiposity, smoking, poverty status, and hypertension. Weighted Poisson regression was used to account for the complex sample design of NHANES II.
Significant at P < 0.01;
CVD at death.